Tuberculosis (TB) treatment challenges in TB-diabetes comorbid patients: a systematic review and meta-analysis

被引:7
作者
Khattak, Mahnoor [1 ]
Rehman, Anees Ur [1 ]
Muqaddas, Tuba [1 ]
Hussain, Rabia [2 ]
Rasool, Muhammad Fawad [1 ]
Saleem, Zikria [1 ]
Almalki, Mesfer Safar [3 ]
Alturkistani, Samar Adel [3 ]
Firash, Shuruq Zuhair [4 ]
Alzahrani, Oseid Mohammed [3 ]
Bahauddin, Ammar Abdulraheem [5 ]
Abuhussain, Safa Almarzooky [4 ]
Najjar, Muath Fahmi [6 ]
Elsabaa, Hossameldeen Mahmoud Ali [6 ]
Haseeb, Abdul [6 ]
机构
[1] Bahauddin Zakariya Univ, Fac Pharm, Dept Pharm Practice, Multan 60800, Pakistan
[2] Univ Sains Malaysia, Sch Pharmaceut Sci, Discipline Social & Adm Pharm, George Town, Malaysia
[3] Minist Interior, Secur Forces Hosp, Mecca, Saudi Arabia
[4] Umm Al Qura Univ, Coll Pharm, Dept Clin Pharm, Mecca, Saudi Arabia
[5] Taibah Univ, Coll Pharm, Dept Pharmacol & Toxicol, Madinah, Saudi Arabia
[6] Al Rayan Private Coll Hlth Sci & Nursing, Dept Clin Pharm, Madinah, Saudi Arabia
关键词
Diabetes mellitus; tuberculosis; comorbidity; extended treatment duration; recurrence; disease progression; TREATMENT OUTCOMES; PULMONARY TUBERCULOSIS; TREATMENT RESPONSE; ACTIVE TUBERCULOSIS; MELLITUS; IMPACT; MANIFESTATIONS; ASSOCIATION; PREVALENCE; CONVERSION;
D O I
10.1080/07853890.2024.2313683
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The Directly Observed Treatment-Short Course (DOTS) Programme was implemented by WHO and includes a combination of four anti-tuberculosis (TB) drugs (isoniazid, pyrazinamide, ethambutol and rifampicin) for a period of six months to eradicate the TB infection completely. Diabetes mellitus (DM) is recognized as one of a strong contributor of TB according to World Health Organization (WHO). The presence of diabetes mellitus type 2 (DM type 2) makes TB treatment complicated. Thus, the objective of the current meta-analysis was to identify and quantify the impact of type 2 DM on treatment outcomes of TB patients treated under the DOTS Programme. Methods This meta-analysis was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Through a systematic review of relevant literature, we focused on studies investigating treatment outcomes including extended treatment duration and recurrence for individuals with both TB and DM undergoing DOTS therapy. The extracted information included study designs, sample sizes, patient characteristics and reported treatment results. Results In 44 studies from different parts of the world, the pooled HR for the impact of DM on extended treatment duration and reoccurrence were HR 0.72, 95% CI 0.56-0.83, p < .01 and HR 0.93, 95% CI 0.70-1.04, p = .08, respectively. The pooled HR for impact of DM on composite TB treatment outcomes was calculated as 0.76 (95% CI 0.60-0.87), p < .01 with an effect size of 41.18. The heterogeneity observed among the included studies was moderate (I2 = 55.79%). Conclusions A negative impact of DM was found on recurrence and extended treatment duration in TB patients treated with DOTS therapy. DM type 2 is responsible for the TB treatment prolongation and TB recurrence rates. By implementing effective management strategies and advancing research, the challenges can be mitigated, arising due to the complex interaction between DM and TB.
引用
收藏
页数:15
相关论文
共 74 条
  • [1] Diabetes mellitus is associated with an increased risk of unsuccessful treatment outcomes among drug-susceptible tuberculosis patients in Ethiopia: A prospective health facility-based study
    Adane, Hawult T.
    Howe, Rawleigh C.
    Wassie, Liya
    Magee, Matthew J.
    [J]. JOURNAL OF CLINICAL TUBERCULOSIS AND OTHER MYCOBACTERIAL DISEASES, 2023, 31
  • [2] Al Amri Sumaiya, 2023, Oman Med J, V38, pe526, DOI 10.5001/omj.2023.82
  • [3] Mycobacterial antigen-induced T helper type 1 (Th1) and Th2 reactivity of peripheral blood mononuclear cells from diabetic and non-diabetic tuberculosis patients and Mycobacterium bovis bacilli Calmette-Guerin (BCG)-vaccinated healthy subjects
    Al-Attiyah, R. J.
    Mustafa, A. S.
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2009, 158 (01) : 64 - 73
  • [4] Prevalence of diabetes mellitus among tuberculosis patients in Sub-Saharan Africa: a systematic review and meta-analysis of observational studies
    Alebel, Animut
    Wondemagegn, Amsalu Taye
    Tesema, Cheru
    Kibret, Getiye Dejenu
    Wagnew, Fasil
    Petrucka, Pammla
    Arora, Amit
    Ayele, Amare Demsie
    Alemayehu, Mulunesh
    Eshetie, Setegn
    [J]. BMC INFECTIOUS DISEASES, 2019, 19 (1)
  • [5] The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis
    Alisjahbana, Bachti
    Sahiratmadja, Edhyana
    Nelwan, Erni J.
    Purwa, Anugrah Maya
    Ahmad, Yana
    Ottenhoff, Tom H. M.
    Nelwan, Ronald H. H.
    Parwati, Ida
    van der Meer, Jos W. M.
    van Crevel, Reinout
    [J]. CLINICAL INFECTIOUS DISEASES, 2007, 45 (04) : 428 - 435
  • [6] Diabetes mellitus and its associated factors among patients with tuberculosis attending directly observed treatment centres in Oyo State, Nigeria: a cross-sectional evaluation
    Anyanwu, Maureen Odochi
    Ajumobi, Olufemi O.
    Afolabi, Nathanael B.
    Usman, Aishat
    Kehinde, Aderemi
    [J]. BMJ OPEN, 2022, 12 (04):
  • [7] The Effect of Diabetes and Prediabetes on Antituberculosis Treatment Outcomes: A Multicenter Prospective Cohort Study
    Arriaga, Maria B.
    Araujo-Pereira, Mariana
    Barreto-Duarte, Beatriz
    Nogueira, Betania
    Freire, Maria Vitoria C. N. S.
    Queiroz, Artur T. L.
    Rodrigues, Moreno M. S.
    Rocha, Michael S.
    Souza, Alexandra B.
    Spener-Gomes, Renata
    Carvalho, Anna Cristina C.
    Figueiredo, Marina C.
    Turner, Megan M.
    Durovni, Betina
    Lapa-E-Silva, Jose R.
    Kritski, Afranio L.
    Cavalcante, Solange
    Rolla, Valeria C.
    Cordeiro-Santos, Marcelo
    Sterling, Timothy R.
    Andrade, Bruno B.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2022, 225 (04) : 617 - 626
  • [8] Ayeni F, 2016, West Afr J Pharm, V27, P1
  • [9] The Effect of Collaborative Care on Treatment Outcomes of Newly Diagnosed Tuberculosis Patients with Type-2 Diabetes Mellitus and Adverse Drug Reaction Presentations: A Prospective Study
    Ayeni, Foluke Adenike
    Oyetunde, Olubukola O.
    Aina, Bolajoko A.
    [J]. INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY, 2021, 10 (03) : 285 - 292
  • [10] The impact of diabetes on tuberculosis treatment outcomes: A systematic review
    Baker, Meghan A.
    Harries, Anthony D.
    Jeon, Christie Y.
    Hart, Jessica E.
    Kapur, Anil
    Loennroth, Knut
    Ottmani, Salah-Eddine
    Goonesekera, Sunali D.
    Murray, Megan B.
    [J]. BMC MEDICINE, 2011, 9